がん病の状況と,それが集中治療師にとって何を意味するのかを理解する
Nina Buchtele1, Laveena Munshi2
1Intensive Care Unit 13i2, Department of Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. nina.buchtele@meduniwien.ac.at.
Medizinische Klinik, Intensivmedizin und Notfallmedizin
|August 29, 2025
まとめ
癌の状態を理解することは 深刻な病気の患者にとって重要です この知識は 集中治療室 (ICU) の治療,診断,回復の目標を より良いがん治療に導くのです
科学分野:
- 腫瘍学
- クリティカル ケア 医療
- 内科 医学
背景:
- 癌の重症患者の管理には 癌の病態を理解することが必要です
- 癌の経路は,治療の継続を含む,重症疾患のタイプ,可逆性,および回復の可能性に影響します.
- 病状 (新診断,寛解,安定,進行) は,集中治療室 (ICU) の差別診断および治療目標に影響します.
研究 の 目的:
- がん患者の重症治療管理に 腫瘍疾患の状況がどう影響するかを検討する.
- ICUの意思決定に 癌の状態を統合する重要性を強調する.
- 集中治療医と腫瘍医の協力の必要性を強調する
主な方法:
- これはレビュー記事です.
- 癌の状況と重症治療に関する現在の知識をまとめています.
- 予後と結果に影響を与える要因について説明します.
主要な成果:
- 重症がん患者の予後は,併発性がん状態と急性重症ケア状態の両方に依存します.
- 患者の弱さや臓器不全の程度 腫瘍の特徴といった要因が 予後に影響します
- ICUでの生存率の改善は,治療への復帰や生活の質などの長期的結果に焦点を当てることが必要である.
結論:
- 腫瘍病状の徹底的な理解は,現実的な目標を設定し,ICUでカスタマイズされたケアを提供するために不可欠です.
- 集中治療医と腫瘍医の緊密な協力により 予後や治療計画や事前のケアに関する議論が改善されます
- 統合された目標指向のケアと 共有された意思決定は 進行中のケアを通して 深刻ながん患者の治療結果を改善します
さらに関連する動画
関連する概念動画
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K


